Blackhawk Capital Partners Llc. Gilead Sciences, Inc. Transaction History

Blackhawk Capital Partners Llc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $440,866 - $488,120	-6,185 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $6,163 - $7,189	95 Added 1.56%	6,185 $438,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $466,176 - $568,320	-6,400 Reduced 51.24%	6,090 $459,000
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $888,663 - $1.04 Million	12,490	12,490 $895,000

1,924

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.